Morgan Stanley Connect Biopharma Holdings LTD Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Morgan Stanley holds 100 shares of CNTB stock, worth $169. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$169% of portfolio
0.0%Shares
11 transactions
Others Institutions Holding CNTB
# of Institutions
19Shares Held
2.61MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN1.82MShares$3.08 Million1.35% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$271,8650.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny144KShares$242,8530.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$175,5750.0% of portfolio
-
Callan Capital, LLC La Jolla, CA80KShares$135,2000.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $93M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...